Milestones and coverage
Since 2017, GoDx has advanced its technology with non-dilutive federal and state support, granted intellectual property, and selective partnerships.
GoDx was accepted into the Rapid Response Partnership Vehicle (RRPV), a BARDA-sponsored consortium managed by Advanced Technology International, connecting government agencies, industry innovators, and research partners focused on national preparedness and next-generation medical countermeasures. As part of RRPV, GoDx will help advance initiatives in pandemic readiness, environmental pathogen surveillance, and rapid diagnostic innovation.
GoDx received a U.S. Defense Health Agency SBIR Phase II contract to advance rapid pathogen surveillance in water and wastewater, supporting biosurveillance and military force health protection.
GoDx received Qualified New Business Venture (QNBV) Program status in Wisconsin, supporting investor tax credits.
GoDx participated as an exhibitor and corporate sponsor at Urgent Care Association EVOLVE.
GoDx was named one of five Phase 2 companies to receive a state matching grant through the SBIR Advance program.
GoDx was featured by the Center for Technology Commercialization for its work transforming the approach to gut health.
The Gazette covered the GoDx and University of Iowa partnership researching rapid testing for diarrheal diseases.
GoDx and the University of Iowa announced a partnership developing a rapid, low-cost test for diarrheal diseases.
GoDx was among eleven Wisconsin small businesses receiving state matching funds to commercialize their innovations.
GoDx was named one of the top startup companies in Wisconsin.
GoDx received its CLIA Certificate of Waiver, assigned in the federal database.
Email info@godiagnostic.com and note that you are working on a story, including your outlet and deadline. Someone from the team will follow up.